2010•The American Journal of the Medical SciencesRequires access

Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma

Sujata Narayanan, Neeraj Agarwal, Kristina P. Callis-Duffin, Julia Anne Batten

Open publisher page 34 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 34 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Sunitinib, Medicine, Renal cell carcinoma, Tyrosine-kinase inhibitor, Sunitinib malate, Vascular endothelial growth factor, Psoriasis, Stromal cell

Back to paper search Browse research topics Original source

Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma — Research Paper | ScholarLens